Alcohol beverages and biochemical changes in blood

Addiction Biology

Volumn 8, Issue 4, 2003, Pages 445-454

  Gorinstein, Shela ^a   Trakhtenberg, Simon ^b  

^a HEBREW UNIVERSITY   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICOAGULANT AGENT; ANTIOXIDANT;

ALCOHOL CONSUMPTION; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; BEVERAGE; BIOCHEMISTRY; BLOOD CHEMISTRY; BLOOD VESSEL WALL; CONSUMER; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CULTURAL ANTHROPOLOGY; DEATH; DIET SUPPLEMENTATION; HUMAN; LIPID BLOOD LEVEL; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

ALCOHOLIC BEVERAGES; ANTICOAGULANTS; ANTIOXIDANTS; CORONARY ARTERIOSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPIDS;

EID: 0347762485     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210310001646420     Document Type: Review

References (102)

1. Gaziano JM. Antioxidant vitamins and coronary artery disease. Am J Med 1994;97:18S-21, 22S-8.
2. Ross R. The pathogenesis of atherosclerosis. In: Braunwald E, editor. Heart Diseases. Philadelphia: W. B. Saunders Co.; 1997, pp. 1105-21.
3. Yla-Herttuala S, Palinsky W, Butler S, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognized epitopes of oxidized low density lipoproteins. Atheroscler Thromb 1994;14:32-40.
4. Frostgard J, Wu R, Guscombe E. Induction of T cell activation by oxidized low density lipoprotein. Atheroscler Thromb 1992;12:461-7.
5. Watanabe T, Haraoka S, Shimokama T. Inflammatory and immunological nature of atherosclerosis. Int J Cardiol 1996;54:S51-60.
6. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-20.
7. Wick G, Pershinka H, Qingbo Xu. Autoimmunity and atherosclerosis. Am Heart J 1999;138:S444-9.
8. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: modifications of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320:915-24.
9. Steinbrecher UP, Zhang H, Londheed M. Role of oxidativity modified LDL in atherosclerosis. Free Radic Biol Med 1990;9:155-68.
10. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
11. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.
12. Genest J, McNamara JR, Ordow MJM et al. Lipoprotein cholesterol, apolipoprotein A-I and B lipoprotein abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992;19:792-802.
13. Hodis HN, Mack WJ, Azen SP et al. Triglyceride-and cholesterol-rich lipoproteins have a different effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastin. Circulation 1994;90:42-9.
14. Brosins FC III, Roberts WS. Significance of coronary artery thrombosis in transmural acute myocardial infarction. A study of 54 necropsy patients. Circulation 1983;63:810-6.
15. Haskell W, Alderman E, Fair J and the SCRIP Investigators. Intensive multiple-risk-factor reduction to modify coronary atherosclerosis in men and women with coronary artery disease. In: Woodford FP, Davignon J, Sniderman A, editors. Atherosclerosis X. Amsterdam: Elsevier, 1995; pp. 565-70.
16. Rimm EB, Ascherio A, Giovannucci E, Spiegalman D, Stampfer M, Willett W. Vegetable, fruits, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447-51.
17. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett, W. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996;125:384-9.
18. Rimm EB, Giovannuci E, Willett WC et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-8.
19. Thun MJ, Peto R, Lopez AD et al. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 1997;337:1456-8.
20. Gorinstein S, Caspi A, Libman I et al. Intrinsic tryptophan fluorescence of human serum proteins and related conformational changes. Protein Chem 2000;19:637-42.
21. Gorinstein S, Caspi A, Goshev I et al. Beer consumption and changes in stability of human serum proteins. J Agric Food Chem 2001; 49:1441-5.
22. Christiansen C, Thomsen C, Rasmussen D et al. Effect of alcohol on glucose, insulin free fatty acids and triacylglycerol responses to a light meal in non insulin dependent diabetic subjects. Br J Nutr 1994;71:449-54.
23. Friedman LA, Kinball AW. Coronary artery disease and alcohol consumption in Framingham. Am J Epidemiol 1986;124:481-9.
24. Sillanaukee P, Koivula T, Jokela H, Pitkäjärvi T, Seppä K. Alcohol consumption and its relation to lipid based cardiovascular risk factors among middle-aged women: the role of HDL3 cholesterol. Atherosclerosis 2000;152:503-10.
25. Hashimoto Y, Futamura A, Nakarai H, Nakahara K. Effect of the frequency of alcohol intake on risk factors for coronary heart disease. Eur J Epidemiol 2001;17:307-12.
26. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
27. Gorinstein S, Zemser M, Lichman I et al. Moderate beer consumption and the blood coagulation in patients with coronary atherosclerosis. J Intern Med 1997;241:47-51.
28. Gorinstein S, Zemser M, Berliner M et al. Moderate beer consumption and positive biochemical changes in patients with coronary artery disease. J Intern Med 1997;242:219-24.
29. Anitschkow N, Chalatow S. Uber experimentelle Cholesterinsteatose und ihre Bedeutung fur die Entstehung einiger pathologischer Prozesse. Centrbl Allg Pathol Pathol Anat 1913;24:1-9.
30. Castelli WB, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-8.
31. Genest J, McNamara JR, Ordow MJM et al. Lipoprotein cholesterol, apolipoprotein A-I and B lipoprotein abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992;19:792-802.
32. Kwiterovich PO, Coresh J, Smith HH, Bachoric PS, Derby CA, Pearson TA. Comparison of plasma level of apolipoprotein B and A-1 and other risk factors in men and in women with premature coronary artery disease. Am J Cardiol 1992;69:1015-21.
33. Gorinstein S, Zemser M, Weisz M, Haruenkit R, Trakhtenberg S. The influence of dry matter of different alcoholic beverages on lipid and protein metabolism and antioxidant activity in serum of rats. J Nutr Biochem 1998;9:131-5.
34. Gorinstein S, Zemser M, Weisz M, Halevy SH, Martin-Belloso O, Trakhtenberg S. The influence of alcohol-containing and alcohol-free beverages on lipid levels and lipid peroxides in serum of rats. J Nutr Biochem 1998;9:682-6.
35. Gorinstein S, Caspi A, Pawelzik E et al. Protein of beer affect lipid levels in rats. Nutr Res 2001;21:1159-69.
36. Gorinstein S, Caspi A, Goshev I et al. Structural changes in plasma circulating fibrinogen after moderate beer consumption as determined by electrophoresis and spectroscopy. J Agric Food Chem 2003;51:822-7.
37. Nakanishi N, Yoshida K, Kawashimo H, Tatara K. Influence of alcohol intake on risk for increased low-density lipoprotein cholesterol in middle-aged Japanese men. Alcohol Clin Exp Res 2001;25:1046-50.
38. Van der Gaag MS, van Tol A, Scheek LM et al. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle aged men. Atherosclerosis 1999;147:405-10.
39. Fuhrman B, Aviram M. Preservation of paraoxenase activity by wine flavonoids - possible role in protection of LDL from lipid peroxidation. Alcohol and wine in health and disease. Ann NY Acad Sci 2002;957:321-4.
40. Bin Ali A, Zhang Q, Lim YK, Fang D, Retnam L, Lim SK. Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation. Free Radic Biol Med 2003;34:824-9.
41. Rozenberg O, Shih DM, Aviram M. Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis - possible role for its phospholipase-A(2)- like activity and lysophosphatidylcholine formation. Ather Thromb Vasc Biol 2003,23:461-7.
42. Marathe GK, Zimmerman GA, McIntyre TM. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoproteinparticles. J Biol Chem 2003;278:3937-47.
43. Sierksma A, van der Gaagt MS, van Tol A, James RW, Hendriks HFJ. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res 2002;26:1430-35.
44. Imhof A, Froelich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001;357:763-7.
45. Perez DD, Strobel P, Foncea R et al. Wine, diet, antioxidant defenses, and oxidative damage. Alcohol and wine in health and disease. Ann NY Acad Sci 2002;957:136-45.
46. Stanley LL, Mazier MJP. Potential explanations for the French paradox. Nutr Res 1999;19:3-15.
47. Belleville J. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. J Nutr 2002;18:173-7.
48. Frankel EN, Kanner J, German GB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipopropein by phenolic substances in red wine. Lancet 1993;341:454-7.
49. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL-C oxidation by resveratol. Lancet 1993;341:1103-4.
50. Mosinger B. Polyphenolics but not alcohol in beer and wine protect serum low-density lipoprotein against atherogenic modification. Cor Vasa 1994;4:171-4.
51. Di Bari M, Zacchei S, Kritchevsky SB et al. Anti-oxidized LDL antibodies and wine consumption: a population-based epidemiological study in Dicomano, Italy. Ann Epidemiol 2003;13:189-95.
52. Gorinstein S, Caspi A, Libman I et al. Positive and negative effects of short-term moderate beer consumption. Alcohol Res 2001,6:233-9.
53. Gorinstein S, Caspi A, Zemser M, Trakhtenberg S. Comparative contents of some phenolics in beer, red and white wines. Nutr Res 2000;1:131-9.
54. Paganga G, Miller N, Rice-Evans CA. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radic Res 1999;30:153-62.
55. Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci 1996;91:449-58.
56. Rifici VA, Schneider SH, Khachadurian AK. Lipoprotein oxidation mediated by J774 murine macrophages is inhibited by individual red wine polyphenols but not by ethanol. J Nutr 2002;132:2532-7.
57. Klatsky AL, Armstrong MA. Alcohol beverages choice and risk of coronary artery disease. Mortality: do red wine drinkers fare best? Am J Cardiol 1993;71:467-9.
58. Wollin SD, Jones PJH. Alcohol, red wine and cardiovascular disease. J Nutr 2002;132:1401-4.
59. Sesso HD, Stamfer MJ, Rosner B, Hennekens CH, Manson JE, Gaziano JM. Seven-year changes in alcohol consumption and subsequent risk of cardiovascular disease in men. Arch Intern Med 2000;160:2605-12.
60. Wannamethee SG, Shaper AG. Taking up regular drinking in middle age: effect on major coronary heart disease event and mortality. Heart 2002;87:32-6.
61. Dimmitt SB, Rakic V, Puddey IB et al. The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial. Blood Coagul Fibrinol 1998;9:39-45.
62. Lacoste L, Hung J, Lam JYT. Acute and delayed antithrombotic effects of alcohol in humans. Am J Cardiol 2001;87:82-5.
63. Mezzano D, Leighton F, Martinez C et al. Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur J Clin Nutr 2001;55:444-51.
64. Brenner H, Rothenbacher D, Bode G, Marz W, Hoffmeister A, Koenig W. Coronary heart disease risk reduction in a predominantly beer-drinking population. Epidemiology 2001;12:390-5.
65. Siersksma A, van der Gaag MS, Schaafsma G, Kluft C, Bakker M, Hendriks FHJ. Moderate alcohol consumption and fibrinolytic factors of pre-and post-menopausal women. Nutr Res 2001;21:171-81.
66. Marquez-Vidal P, Montaye M, Haas B et al. Relationship between alcoholic beverages and cardiovascular risk factor levels in middle-aged men: the Prime study. Atherosclerosis 2001;157:431-40.
67. Mukamal KJ, Jadhav PP, D'Agostino RB et al. Alcohol consumption and hemostatic factors. Analysis of the Framingham Offspring cohort. Circulation 2001;104:1367-73.
68. Buemann B, Dyerberg J, Astrup A. Alcohol drinking and cardiac risk. Nutr Res Rev 2002;15:91-121.
69. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001;936:11-30.
70. Palmieri V, Celentano A, Roman MJ de et al. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J 2003;145:467-74.
71. Mermen LI, Balkau B, Vol S, Caces E, Eschwege E. Fibrinogen - a possible link between alcohol consumption and cardiovascular disease? Arterioscler Thromb Vasc Biol 1999;19:887-92.
72. Wang ZQ, Baker TH, Fuller GM. Alcohol at moderate levels decreases fibrinogen expression in vivo and in vitro. Alcohol Clin Exp Res 1999;23:1927-32.
73. Sierksma A, van der Gaag WS, Kluft S, Hendriks HFJ. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 2002;56:1130-6.
74. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Bohm M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the "French paradox". FASEB J 2002;16:U192-211.
75. Parks DA, Booyse FM. Cardiovascular protection by alcohol and polyphenols - role of nitric oxide. Alcohol and wine in health and disease. Ann NY Acad Sci 2002;957:115-21.
76. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002;106:1614-17.
77. Iijima K, Yoshizumi M, Ouchi Y. Effect of red wine polyphenols on vascular smooth muscle cell function-molecular mechanism of the "French paradox". Mech Ageing Dev 2002;123:1033-9.
78. De Lorgeril M, Salem P, Boucher F, de Leiris J, Paillard F. Effect of wine ethanol on serum iron and ferritin levels in patients with coronary heart disease. Nutr Metab Cardiovasc Dis 2001;11:176-80.
79. Whitfield JB, Zhu G, Hearth AC, Powell LW, Martin NG. Effects of alcohol consumption on indices of iron stores and iron on alcohol intake markers. Alcohol Clin Exp Res 2001;25:1037-45.
80. Gorinstein S, Zemser M, Libman I, Trakhtenberg S, Caspi A. Effect of beer consumption on plasma magnesium: randomized comparison with mineral water. J Roy Soc Med 1998;91:631-3.
81. Vliegenthart R, Geleijnse JM, Hofman A et al. Alcohol consumption and risk of peripheral arterial disease - the Rotterdam Study. Am J Epidemiol 2002;155:332-8.
82. Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ. Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta - Mol Basis Dis 2003;1637:59-69.
83. Zou JG, Wang ZR, Huang YZ, Cao KJ, Wu JM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med 2003;11:317-20.
84. Cuevas AM, Guasch V, Castillo O et al. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers. Lipids 2000;35:143-8.
85. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 2001;8:3-17.
86. Buemann B, Dyerberg J, Astrup A. Alcohol drinking and cardiac risk. Nutr Res Rev 2002;15:91-121.
87. Deckert V, Desrumaux C, Athias A et al. Prevention of LDL alpha-tocopherol consumption, cholesterol oxidation, and vascular endothelium dysfunction by polyphenolic compounds from red wine. Atherosclerosis 2002;165:41-50.
88. Leger AS, Cochrane AL, Moore I. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1:1017 -20.
89. Moor RD, Pearson TA. Moderate alcohol consumption and coronary disease. Medicine 1986;65:246-67.
90. Carando S, Teissedre PL, Leger C, Cabanis JC. Wine, beer and spirits consumption and cardiovascular diseases. Sci Aliments 1998;18:115-27.
91. Cestaro B, Simonetti P, Cervato G, Brusomolino A, Gatti P, Testolin G. Red wine effects on peroxidation indexes of rat plasma and erythrocytes. Int J Food Sci Nutr 1996;47:181-9.
92. Cascon E, Roig R, Ardevol A, Salvado MJ, Arola L, Blade C. Nonalcoholic components in wine reduce low density lipoprotein cholesterol in normocholesterolemic rats. Lipids 2001;36:383-8.
93. Auger C, Caporiccio B, Landrault N et al. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters (Mesocricetus auratus). J Nutr 2002;132:1207-13.
94. Fuhrman D, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
95. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol free red wine enhances plasma antioxidant capacity in humans. J Nutr 1998;128:1003-7.
96. Carbonneau MA, Leger CL, Descomps B, Michel F, Monnier L. Improvement in the antioxidant status of plasma and low-density lipoprotein in subjects receiving a red wine phenolics mixture. J Am Oil Chem Soc 1998;75:235-40.
97. Ghiselli A, Natella F, Guidi A, Montanari L, Fantozzi P, Scaccini C. Beer increases plasma antioxidant capacity in humans. J Nutr Biochem 2000;11:76-80.
98. Aviram M, Fuhrman B. Wine flavonoids protect against LDL oxidation and atherosclerosis. Alcohol and wine in health and disease. Ann NY Acad Sci 2002;957:146-61.
99. Goldberg DM, Hoffman B, Yang J, Soleas GJ. Phenolic constituents, furans, and total antioxidant status of distilled spirits. J Agric Food Chem 1999;47:3978-85.
100. Van der Gaag MS, van den Berg R, van den Berg H, Schaafsma G, Hendriks HFJ. Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men. Eur J Clin Nutr 2000;54:586-91.
101. Llerena IR, Huerta EM. Wine and the heart. Rev Esp Cardiol 1998;51:435-49.
102. Corrao G, Rubbiati L, Zambon A, Aricò S. Alcohol-attributable and alcohol-preventable mortality in Italy: a balance in 1983 and 1996. Eur J Public Health 2002;12:214-23.